CD36: Linking lipids to the NLRP3 inflammasome, atherogenesis and atherothrombosis

Cellular and Molecular Immunology

Volumn 11, Issue 1, 2014, Pages 8-10

  Oury, Cécile ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; INFLAMMASOME; LIPID LINKED PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PURINERGIC P2X7 RECEPTOR; REACTIVE OXYGEN METABOLITE; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR CD36; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ATHEROGENESIS; CD36 GENE; CHOLESTEROL EMBOLISM; ENDOPLASMIC RETICULUM STRESS; GENE; GENE EXPRESSION; HUMAN; INFLAMMATION; LIPID ANALYSIS; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PROTEIN MODIFICATION; THROMBOSIS;

ALZHEIMER DISEASE; ANIMALS; ANTIGENS, CD36; ATHEROSCLEROSIS; CARRIER PROTEINS; DIABETES MELLITUS, TYPE 2; INFLAMMATION;

EID: 84891777013     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2013.48     Document Type: Article

References (15)

1. Sheedy FJ, Grebe A, Rayner KJ, Kalantari P, Ramkhelawon B, Carpenter SB et al. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol 2013; 14: 812-820.
2. Manning-Tobin JJ, Moore KJ, Seimon TA, Bell SA, Sharuk M, Alvarez-Leite JI, et al. Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arterioscler Thromb Vasc Biol 2009; 29: 19-26.
3. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 2010; 11: 155-161.
4. Seimon TA, Nadolski MJ, Liao X, Magallon J, Nguyen M, Feric NT et al. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab 2010; 12: 467-482.
5. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010; 464: 1357-1361.
6. Rajamaki K, Lappalainen J, Oorni K, Valimaki E, Matikainen S, Kovanen PT et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PloS ONE 2010; 5: e11765.
7. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440: 228-232.
8. Lamkanfi M, Dixit VM. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 2012; 28: 137-161.
9. Juliana C, Fernandes-Alnemri T, Kang S, Farias A, Qin F, Alnemri ES. Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation. J Biol Chem 2012; 287: 36617-36622.
10. Py BF, Kim MS, Vakifahmetoglu-Norberg H, Yuan J. Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol Cell 2013; 49: 331-338.
11. Munoz-Planillo R, Kuffa P, Martinez-Colon G, Smith BL, Rajendiran TM, Nunez G. K1 efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 2013; 38: 1142-1153.
12. Gidlof O, Smith JG, Melander O, Lovkvist H, Hedblad B, Engstrom G et al. A common missense variant in the ATP receptor P2X7 is associated with reduced risk of cardiovascular events. PloS ONE 2012; 7: e37491.
13. Wraith KS, Magwenzi S, Aburima A, Wen Y, Leake D, Naseem KM. Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways. Blood 2013; 122: 580-589.
14. Furlan-Freguia C, Marchese P, Gruber A, Ruggeri ZM, Ruf W. P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice. J Clin Invest 2011; 121: 2932-2944.
15. Rac M, Safranow K, Kurzawski G, Krzystolik A, Chlubek D. Is CD36 gene polymorphism in region encoding lipid-binding domain associated with early onset CAD? Gene 2013; in press.